tf

Please join us to hear a world expert on Treg immunobiology and CTLA-4 regulation.

Thanks for hosting me so well Todd, I had a fantastic visit - so much exciting research going on at UF Diabetes Institute !

Prof Andrew McMichael has been elected as one of four international members of National Academy of Sciences from the University of Oxford! A mark of excellence in science, Prof McMichael has been recognised for his achievements in original #ScientificResearch 👏🔬 Read more 👉 ndm.ox.ac.uk/news/andrew-mc…

Researchers at Translational Gastroenterology & Liver Unit (TGLU) and Centre for Human Genetics have found that the structure of immune cells in the gut may be driving a gluten response in people with #CoeliacDisease 🌾🔬 Their findings could lead to new treatments and potentially a cure. Read more 👉 ndm.ox.ac.uk/news/coeliac-d…

Congratulations Sadaf! Farooqi Lab

Oxford and Thai health officials have signed a Memorandum of Understanding to collaborate on research with the aim to prevent and control the key #InfectiousDiseases affecting the Thai-Myanmar border 🇹🇭 🇲🇲 🦠 MORU Find out more 👉 ndm.ox.ac.uk/news/ndm-profe…

Congratulations to the eight NDM researchers who have been awarded Associate Professorships in recognition of their research or teaching 👏🎉 Nayia Petousi Alice Norton Katherine Bull Abdirahman Abdi Read more 👉 ndm.ox.ac.uk/news/eight-ndm…

Children with early-stage T1D are being managed by our paediatric diabetes colleagues across the UK. Our UK-wide survey outlines the current status of their management, and the need for a UK-consensus approach to early stage T1D onlinelibrary.wiley.com/doi/10.1111/dm…

Our systematic review and meta-analysis shows that in children with early-stage #T1D the OGTT, related tests (M120 and Index60) and HbA1c predict progression to clinical #T1D. More evidence is needed for other tests, such as CGM and C-peptide. Rachel Besser T1Early Diabetic Medicine Wiley

Huge pleasure to meet Charlotte whose new book will be dynamite to medical pretensions but huge force for patient empowerment. Anyone who's trying to envision AI-informed models of care needs to talk to Charlotte Blease, PhD And by the way, there is no other future for medicine.

Awesome Stanford Office of Technology Licensing (OTL) spotlight on Appel Sauce Studios, who is commercializing the injectable hydrogel depot technology we've developing over the past few years @stanford Stanford UniversityMSE: otl.stanford.edu/about/about-ot…

We're thrilled that Professor Peter Flatt has been awarded an MBE in the King’s Birthday Honours list – a richly deserved recognition of his outstanding career in #diabetesresearch 🙌 A thread 👇

Ben Todd has written the best thing on how to plan your career given AI/AGI. Will thread. A very plausible scenario is salaries for the right work go up 10x over a ~decade, before then falling to 0. So we might be heading for a brief golden age followed by crazy upheaval. 1/

Nicole Soranzo European Research Council (ERC) Human Technopole Wellcome Sanger Institute Cambridge University Amazing, congrats Nicole Soranzo, well deserved indeed! 👏

👏👏 What a great event! Our CEO attended to give a talk on 'How the discovery of ReNU syndrome is impacting patients and families', which you can now watch in the recordings linked below. cpm.ox.ac.uk/lecture/how-th…

The difference between 100% and 99% automation is massive. In the first, wages increase then collapse.

Not just shingles vaccine, but also RSV vaccine reduces the risk of dementia, which highlights the benefit of revving up the immune system in older individuals nature.com/articles/s4154…

Probably the most promising use of proteomics in drug development is creating signatures that act as surrogates for hard endpoints in early phase trials. In a MASH trial, semaglutide showed dose-dependent effects on serum proteomic signatures of liver histology mirroring actual